Company Filing History:
3 out of 4 
2 out of 2 
1 out of 1 Years Active: 2015-2023
Title: The Innovative Contributions of Matthew Rein Scholz
Introduction
Matthew Rein Scholz is a prominent inventor based in Seattle, WA, known for his significant contributions to the field of biotechnology. With a total of 6 patents, Scholz has focused on developing advanced therapeutic solutions that target specific cells associated with aging and disease.
Latest Patents
Scholz's latest patents include groundbreaking work on fusogenic lipid nanoparticles designed for the target cell-specific production of therapeutic proteins. These innovations provide nucleic acid-based expression constructs aimed at producing pro-apoptotic proteins within target cells, particularly senescent and cancer cells. His formulations and systems, including fusogenic lipid nanoparticle (LNP) formulations, are designed to deliver these constructs effectively. The methods developed by Scholz aim to reduce, prevent, and eliminate the growth and survival of cells associated with aging and disease, showcasing his commitment to advancing medical treatments.
Career Highlights
Throughout his career, Matthew Rein Scholz has worked with notable companies such as Immusoft Corporation and Oisin Biotechnologies, Inc. His experience in these organizations has allowed him to refine his expertise in biotechnology and therapeutic development.
Collaborations
Scholz has collaborated with talented individuals in the field, including Eric J Herbig and Mei Xu. These partnerships have contributed to the advancement of his innovative projects and patents.
Conclusion
Matthew Rein Scholz's work exemplifies the spirit of innovation in biotechnology, with a focus on developing targeted therapies for aging and disease. His contributions continue to impact the field significantly, paving the way for future advancements in medical science.